Prevalence of Intrauterine Adhesions After Abdominal Myomectomy
NCT ID: NCT04030273
Last Updated: 2021-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2022-01-31
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is accepted that injury to the endometrium is generally considered to be the primary causative factor for the development of intrauterine adhesions. The reason for such a high incidence of intrauterine adhesions after open myomectomy is unclear. It is speculated that infection or in adverted closure of the uterine cavity may play a role in intrauterine adhesion formation. The relationship between the number of fibroids removed and the risk of adhesions suggests a traumatic etiology. In the preservation of the uterus for the purpose of fertility, it is essential to also understand the impact of myomectomy on the endometrium. Currently no guideline recommends in office hysteroscopy as follow-up after myomectomy. The purpose of the present study is to evaluate the frequency of uterine adhesions following myomectomy and the impact of number, size and location of the fibroids as well as intraoperative breach of the endometrial cavity at the time of the myomectomy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pregnancy Outcomes Following Myomectomy
NCT06474065
Misoprostol Versus Oxytocin Infusion On Reducing Blood Loss During Abdominal Myomectomy
NCT06325501
Myomectomies:Tumor Characteristics and Clinical Implications
NCT02671253
The Benefits and Limits of Laparoscopic Surgery for Uterine Fibroids
NCT00860002
Incidence of Intrauterine Adhesions After Myomectomy With Intrauterine Anti-Adhesion Gel
NCT07280286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open (laparotomic) myomectomy
Women undergoing uterine myomectomy by open surgery (laparotomy).
Diagnostic hysteroscopy
Diagnostic hysteroscopy performed in outpatient setting, using "no touch" vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.
Laparoscopic myomectomy
Women undergoing uterine myomectomy by laparoscopy.
Diagnostic hysteroscopy
Diagnostic hysteroscopy performed in outpatient setting, using "no touch" vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.
Robotic myomectomy
Women undergoing uterine myomectomy by robotic surgery.
Diagnostic hysteroscopy
Diagnostic hysteroscopy performed in outpatient setting, using "no touch" vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic hysteroscopy
Diagnostic hysteroscopy performed in outpatient setting, using "no touch" vaginoscopy technique with a 2.9 mm 30-degree rigid hysteroscope with a single inflow sheet using normal saline as distention media.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Desire to preserve fertility/uterus
* Myomectomy (by laparotomy, laparoscopy or robotic approach).
Exclusion Criteria
* Pregnant women
* Prisoners
* History of previous intrauterine procedures such as dilation and curettage
* History of known intrauterine adhesions
* History of documented pelvic inflammatory disease
* History of endometritis (acute or chronic)
* Hysteroscopic myomectomy
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Università degli Studi dell'Insubria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antonio Simone Laganà
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jose Carugno
Role: STUDY_DIRECTOR
University of Miami
Andrea Tinelli
Role: STUDY_CHAIR
Vito Fazzi Hospital
Antonio Simone Laganà
Role: STUDY_CHAIR
Università degli Studi dell'Insubria
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Lagana AS, Garzon S, Dababou S, Uccella S, Medvediev M, Pokrovenko D, Babunashvili EL, Buyanova SN, Schukina NA, Shcherbatykh Kaschchuk MG, Kosmas I, Licchelli M, Panese G, Tinelli A. Prevalence of Intrauterine Adhesions after Myomectomy: A Prospective Multicenter Observational Study. Gynecol Obstet Invest. 2022;87(1):62-69. doi: 10.1159/000522583. Epub 2022 Feb 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ADAM-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.